You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients

 

Online download statistics by month:

Online download statistics by month: March 2021 to July 2025

AbstractFullPdf
Mar 2021234234133
Apr 2021268268169
May 2021228228135
Jun 202113713760
Jul 202113913963
Aug 202113613642
Sep 2021878747
Oct 202110810877
Nov 202111211256
Dec 2021969972
Jan 2022879263
Feb 2022687149
Mar 20229310369
Apr 202211312584
May 2022929851
Jun 2022808337
Jul 2022626746
Aug 2022787955
Sep 2022798057
Oct 20229910354
Nov 2022869663
Dec 2022555935
Jan 2023616330
Feb 2023858638
Mar 2023929472
Apr 2023686843
May 2023717239
Jun 2023464718
Jul 2023606440
Aug 2023687336
Sep 2023576033
Oct 2023575841
Nov 2023657544
Dec 2023535325
Jan 2024697343
Feb 2024404624
Mar 2024114125105
Apr 2024707442
May 2024515631
Jun 2024585926
Jul 2024818740
Aug 2024494816
Sep 2024606127
Oct 2024575833
Nov 2024646751
Dec 2024787936
Jan 2025858436
Feb 2025484829
Mar 2025788049
Apr 202510910939
May 2025878739
Jun 2025383814
Jul 2025110
Total455746972656